AN2 Therapeutics director Robin Shane Readnour reports disposal of common shares worth $97,645.76
ANTX•Director reports common stock sales
- AN2 Therapeutics director Robin Shane Readnour reported sales of common stock on Sept. 3 and Sept. 8.
- Total shares sold: 16,119; weighted average prices: $6.07 and $6.02.
- Indirect holdings stood at 562,715 shares and 630,644 shares after Sept. 3 transactions.
- Indirect holdings stood at 557,990 shares and 625,350 shares after Sept. 8 transactions.
- Readnour also reported 9,077 shares held directly.
Related News
Paine Schwartz Food Chain Fund V GP reports $3.16 million Suja Life Class A stock purchase
SUJA•
Blackstone Names David Levine And Giovanni Cutaia As Real Estate Heads To Succeed Departing Meghji - Bloomberg News
BX•
